Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-19-018099
Filing Date
2019-05-09
Accepted
2019-05-09 17:13:11
Documents
4
Effectiveness Date
2019-05-09

Document Format Files

Seq Description Document Type Size
1 2019 S-8 snss-s8.htm S-8 264180
2 EX-5.1 snss-ex51_7.htm EX-5.1 10903
3 EX-23.1 snss-ex231_6.htm EX-23.1 2880
4 GRAPHIC g1y0tww531xu000001.jpg GRAPHIC 2548
  Complete submission text file 0001564590-19-018099.txt   282782
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-231342 | Film No.: 19811737
SIC: 2834 Pharmaceutical Preparations